These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12840112)

  • 1. TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis.
    Matakidou A; Eisen T; Houlston RS
    Mutagenesis; 2003 Jul; 18(4):377-85. PubMed ID: 12840112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the TP53 polymorphisms and lung cancer risk: a meta-analysis.
    Ye XH; Bu ZB; Feng J; Peng L; Liao XB; Zhu XL; Sun XL; Yu HG; Yan DF; Yan SX
    Mol Biol Rep; 2014 Jan; 41(1):373-85. PubMed ID: 24271138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP1A1 polymorphisms and lung cancer risk: a meta-analysis.
    Houlston RS
    Pharmacogenetics; 2000 Mar; 10(2):105-14. PubMed ID: 10761998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer.
    Zhang X; Miao X; Guo Y; Tan W; Zhou Y; Sun T; Wang Y; Lin D
    Hum Mutat; 2006 Jan; 27(1):110-7. PubMed ID: 16287156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No association of TP53 codon 72 and intron 3 16-bp duplication polymorphisms with breast cancer risk in Chinese Han women: new evidence from a population-based case-control investigation.
    Hao W; Xu X; Shi H; Zhang C; Chen X
    Eur J Med Res; 2018 Oct; 23(1):47. PubMed ID: 30309383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53 gene polymorphisms at codons 11, 72, and 248 and association with endometriosis in a Brazilian population.
    Camargo-Kosugi CM; D'Amora P; Kleine JP; Carvalho CV; Sato H; Schor E; Silva ID
    Genet Mol Res; 2014 Aug; 13(3):6503-11. PubMed ID: 25177931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation on the role of p53 codon 72 polymorphism and interactions with tobacco, betel quid, and alcohol in susceptibility to cancers in a high-risk population from North East India.
    Ihsan R; Devi TR; Yadav DS; Mishra AK; Sharma J; Zomawia E; Verma Y; Phukan R; Mahanta J; Kataki AC; Kapur S; Saxena S
    DNA Cell Biol; 2011 Mar; 30(3):163-71. PubMed ID: 21043833
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Cavic M; Spasic J; Krivokuca A; Boljevic I; Kuburovic M; Radosavljevic D; Jankovic R
    J Clin Pathol; 2019 Jan; 72(1):75-80. PubMed ID: 30467244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis.
    Zhuo XL; Cai L; Xiang ZL; Zhuo WL; Wang Y; Zhang XY
    Arch Med Res; 2009 May; 40(4):299-305. PubMed ID: 19608020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TP53 codon 72 polymorphism and breast cancer risk in Bangladeshi population.
    Hossain A; Murshid GMM; Zilani MNH; Islam F; Sultana R; Sultana T; Hossain MG; Rahman MM
    Breast Cancer; 2017 Jul; 24(4):571-578. PubMed ID: 27837441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of p53 codon 72 polymorphism and survival of North Indian lung cancer patients treated with platinum-based chemotherapy.
    Kumari A; Bahl C; Singh N; Behera D; Sharma S
    Mol Biol Rep; 2016 Dec; 43(12):1383-1394. PubMed ID: 27614750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk.
    Miller DP; Liu G; De Vivo I; Lynch TJ; Wain JC; Su L; Christiani DC
    Cancer Res; 2002 May; 62(10):2819-23. PubMed ID: 12019159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of TP53 mutations in relation to Arg72Pro genotypes in non small cell lung cancer.
    Lind H; Ekstrøm PO; Ryberg D; Skaug V; Andreassen T; Stangeland L; Haugen A; Zienolddiny S
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2077-81. PubMed ID: 17932356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between TP53 Arg72Pro polymorphism and lung cancer susceptibility: evidence from 30,038 subjects.
    Qiao Q; Hu W
    Lung; 2013 Aug; 191(4):369-77. PubMed ID: 23595658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the p53 codon 72 and intron 3 polymorphisms on non-small cell lung cancer (NSCLC) prognosis.
    Boldrini L; Gisfredi S; Ursino S; Lucchi M; Greco G; Mussi A; Donati V; Fontanini G
    Cancer Invest; 2008 Mar; 26(2):168-72. PubMed ID: 18259947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms.
    Popanda O; Edler L; Waas P; Schattenberg T; Butkiewicz D; Muley T; Dienemann H; Risch A; Bartsch H; Schmezer P
    Lung Cancer; 2007 Jan; 55(1):25-34. PubMed ID: 17059853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.
    Szymanowska A; Jassem E; Dziadziuszko R; Borg A; Limon J; Kobierska-Gulida G; Rzyman W; Jassem J
    Lung Cancer; 2006 Apr; 52(1):9-14. PubMed ID: 16499995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intron 3 16 bp duplication polymorphism of TP53 contributes to cancer susceptibility: a meta-analysis.
    Hu Z; Li X; Qu X; He Y; Ring BZ; Song E; Su L
    Carcinogenesis; 2010 Apr; 31(4):643-7. PubMed ID: 20089604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on TP53 codon 72 polymorphisms with oral carcinoma susceptibility.
    Zhuo XL; Li Q; Zhou Y; Cai L; Xiang ZL; Yuan W; Zhang XY
    Arch Med Res; 2009 Oct; 40(7):625-34. PubMed ID: 20082880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of TP53 codon 72 and CDH1 genetic polymorphisms with colorectal cancer risk in Bangladeshi population.
    Rivu SF; Apu MNH; Shabnaz S; Nahid NA; Islam MR; Al-Mamun MMA; Nahar Z; Rabbi SNI; Ahmed MU; Islam MS; Hasnat A
    Cancer Epidemiol; 2017 Aug; 49():46-52. PubMed ID: 28554075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.